If an epigenetic set point controlling Ecrg4 expression and regulating Ecrg4 activity in normal tissues exists, then the results here suggest that therapeutics targeting Ecrg4 may modulate mucosal epithelial resistance to infection. This evidence concerns the gene ECRG4 and infection.